An­oth­er SPAC is gear­ing up to go pub­lic, this time com­ing from Oleg Nodel­man's EcoR1 Cap­i­tal

Ed­i­tor’s note: In­ter­est­ed in fol­low­ing bio­phar­ma’s fast-paced IPO mar­ket? You can book­mark our IPO Track­er here.

It’s an­oth­er week in the biotech in­dus­try, which these days can on­ly mean one thing: An­oth­er SPAC has filed to go pub­lic.

This time, it’s EcoR1 Cap­i­tal re­turn­ing to the re­verse-merg­er mar­ket, with Oleg Nodel­man’s firm sub­mit­ting its SEC pa­per­work Tues­day to the tune of an es­ti­mat­ed $150 mil­lion raise. Called Panacea Ac­qui­si­tion II, the blank-check com­pa­ny will be EcoR1’s sec­ond SPAC to go pub­lic over the last nine months af­ter the first Panacea launched last June.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER